EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Intralesional Immunotherapy for Non-Genital Viral Warts: A Review of Current Evidence and Future Perspectives

Emilia Kucharczyk iD, Karolina Pawłuszkiewicz iD, Karol Biliński, Joanna Maj, Małgorzata Ponikowska

International Journal of Molecular Sciences · 12.06.2025 · 26 (12) · 5644

DOI: 10.3390/ijms26125644 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 12.06.2025. Verfasst von Emilia Kucharczyk und 4 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Wroclaw Medical University, Wybrzeże L. Pasteura 1, 50-367 Wroclaw, Poland. Hauptthemen laut MEDLINE: Warts, Immunotherapy. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 149 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wroclaw Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cutaneous warts caused by human papillomavirus (HPV) are among the most common dermatological conditions, affecting the quality of life of numerous people. Although they are widespread, effective and reliable treatment alternatives are limited, emphasizing the necessity for novel treatment options. Intralesional immunotherapy has emerged as a promising alternative, aiming to stimulate the host immune response to achieve the clearance of both treated and distant lesions. This review explores the immunopathogenesis of cutaneous warts and provides an in-depth analysis of intralesional therapies including measles–mumps–rubella (MMR) vaccine, purified protein derivative (PPD), Bacillus Calmette–Guérin (BCG), Candida antigen, Mycobacterium w vaccine (MWV), vitamin D3, and autoinoculation. We provide a comprehensive analysis of the most promising modalities, highlighting their mechanism of action, outcomes, advantages, and limitations. Although initial data indicate that intralesional immunotherapy offers advantageous efficacy and tolerability, there is a lack of standardized treatment protocols and randomized controlled trials to endorse its broad application. Nevertheless, considering its potential to address local and distant lesions with minimal adverse effects, intralesional immunotherapy may represent a transformative approach to managing cutaneous warts.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

WartsImmunotherapyHumansInjections, Intralesional

Stichwörter der Autor:innen

immunomodulationintralesional therapyviral warts

Autor:innen und Institutionen

  • Faculty of Medicine, Wroclaw Medical University, Wybrzeże L. Pasteura 1, 50-367 Wroclaw, Poland.
  • Clinical Department of General Dermatology, Centre of General Dermatology Oncodermatology, Wroclaw Medical University, 50-556 Wroclaw, Poland.

ORCID-Profile: Emilia Kucharczyk, Karolina Pawłuszkiewicz

Förderung

  • Wroclaw Medical University

Zitieren

APA

Kucharczyk, E., Pawłuszkiewicz, K., Biliński, K., Maj, J., & Ponikowska, M. (2025). Intralesional Immunotherapy for Non-Genital Viral Warts: A Review of Current Evidence and Future Perspectives. International Journal of Molecular Sciences, 26(12), 5644. https://doi.org/10.3390/ijms26125644

Vancouver

Kucharczyk E, Pawłuszkiewicz K, Biliński K, Maj J, Ponikowska M. Intralesional Immunotherapy for Non-Genital Viral Warts: A Review of Current Evidence and Future Perspectives. International Journal of Molecular Sciences. 2025;26(12):5644. doi:10.3390/ijms26125644

BibTeX
@article{Kucharczyk2025,
  author = {Kucharczyk, Emilia and Pawłuszkiewicz, Karolina and Biliński, Karol and Maj, Joanna and Ponikowska, Małgorzata},
  title = {Intralesional Immunotherapy for Non-Genital Viral Warts: A Review of Current Evidence and Future Perspectives},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {12},
  pages = {5644},
  doi = {10.3390/ijms26125644}
}
Kostenlos starten →